Georgia-Pacific Plans $1B+ Expansion to Boost Premium Tissue Capacity
Event summary
- Georgia-Pacific begins final engineering for new structured paper machines to meet premium tissue demand.
- First machine expected to start operations in late 2028, with a second to follow.
- Company evaluating U.S. central and western facilities for expansion, with site selections pending.
- Investments aim to support long-term growth for branded and private-label product portfolios.
The big picture
Georgia-Pacific's expansion reflects the broader trend of premiumization in the tissue market, driven by consumer demand for higher-quality products. The move also underscores the company's strategy of leveraging existing infrastructure to optimize capital deployment, a key advantage in an industry facing rising input costs. With this investment, Georgia-Pacific aims to solidify its position as a top-tier supplier in both branded and private-label segments.
What we're watching
- Execution Risk
- Whether Georgia-Pacific can deliver on its 2028 operational timeline amid potential supply chain constraints.
- Market Positioning
- How this expansion will affect Georgia-Pacific's competitive stance against Procter & Gamble and Kimberly-Clark in the premium tissue segment.
- Private-Label Growth
- The pace at which private-label partnerships will contribute to revenue growth following the capacity increase.